SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

US Senators Reach Deal on Capping Insulin Costs At $35 Per Month, Semafor Reports

A bipartisan group of ⁠U.S. senators has reached a ⁠deal on capping the ⁠price of ‌a month's supply of insulin at $35, Semafor reported on Wednesday, citing ‌an interview...

Metabolically Healthy Obesity in Kids May Raise Disease Risk

Children with metabolically healthy obesity face higher risks for type 2 diabetes and dyslipidemia by 30 years of age than children in the general population.

India Drug Regulator Tightens Surveillance Against Unauthorised Weight-loss Drug Sales

India's drug regulator has tightened surveillance against the unauthorised sale and promotion of weight-loss drugs, the health ⁠ministry said on Tuesday, after local...

Body Map Reveals Widespread Pain in Chronic Pancreatitis

A self-reported electronic body map reveals that widespread pain is common in patients with chronic pancreatitis and abdominal pain and is linked to more severe pain.

College Behavior Influences Lifestyle, Weight, Decades Later

Unhealthy eating habits in college persist into early adulthood, a decade or more later, and are linked to greater weight gain, results from a longitudinal study show.

Long-Term Steroid Use Linked to Adrenal Insufficiency

Long-term use of systemic corticosteroids is linked to adrenal insufficiency and related hospitalisation, whereas long-term use of inhaled corticosteroids is modestly linked to adrenal insufficiency.

New Drug Shows Promise for Menopausal Hot Flushes and Sleep

Elinzanetant demonstrates superior or comparable efficacy to existing non-hormonal treatments in reducing the frequency of menopausal hot flushes while significantly improving sleep.

GLP-1s Prevent Death as a Result of Substance Use Disorders

New research shows reduction in addiction and deaths while using GLP-1s.

Dementia, AD Risk Nearly Double in Advanced CKM Syndrome

EyePoint Sues Rival Ocular Therapeutix, Alleging False Claims About Eye Drug

EyePoint filed a lawsuit on Friday accusing rival Ocular Therapeutix of spreading false or ⁠misleading information about EyePoint and its lead experimental eye...

Postmenopausal Bone Gains From Exercise May Plateau

Younger women and those with normal BMI who met certain thresholds for weekly moderate-intensity physical activity experienced improved lumbar spine health, according to an analysis of NHANES data.

Diabetes Drug Shortages: Where Things Stand and What to Know

While most shortages have eased, some important medications remain in short supply.

Brazilian 10-Year Diabetes Risk Calculator

A Brazilian calculator using up to 12 clinical and laboratory predictors estimates an individual’s 10 year diabetes risk and may better prioritize patients for prevention than FINDRISC.

Judge Says he Will Bar RFK Move Aimed At Cutting Gender-affirming Care for Minors

A U.S. judge on Thursday said he would block an effort by Health Secretary Robert F. Kennedy Jr that would have sharply restricted medical providers from ⁠providing gender...

Eye Condition Risk Elevated With Semaglutide, but Still Low

New VA database study is the latest to find a small but significant increased risk for nonarteritic anterior ischemic optic neuropathy.

Axitinib Ups Neuroendocrine Tumor Objective Response Rate

Patients were randomly assigned 1:1 to receive either axitinib 5 mg orally twice daily or matching placebo, both combined with octreotide long-acting release 30 mg, in an international study.